정책동향
고성장 비즈니스 지원을 위한 연방연구 기술이전 및 상용화 계획 - NIH
- 등록일2013-06-03
- 조회수5911
- 분류정책동향 > 기타 > 기타
-
자료발간일
2012-09-18
-
출처
http://www.ott.nih.gov
-
원문링크
-
키워드
#연방연구 기술이전
- 첨부파일
고성장 비즈니스 지원을 위한 연방연구 기술이전 및 상용화 계획 - NIH
The NIH Plan for Accelerating Technology Transfer and Commercialization of Federal Research in Support of High Growth Businesses
Introduction
The National Institutes of Health (NIH) is the nation’s biomedical research agency. The NIH’s extramural funding supports research at more than 3,000 institutions. A portion of this funding supports the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which play a critical role in supporting the agency’s mission to improve human health. The programs are uniquely positioned to convert basic research ideas into commercially viable products and services available to the general public. The NIH intramural program includes about 6,000 scientists working at the NIH. Their output of inventions has grown over the years, resulting in the largest biomedical patent and licensing portfolio among public sector institutions worldwide. The NIH has achieved great success in licensing inventions made by the scientists who work at the NIH and the U.S. Food and Drug Administration (FDA), with 25 FDA approved products and hundreds of others having reached the market. NIH scientists have collaborated with other institutions, both for-profit and non-rofit, to leverage the scientific discoveries that ultimately benefit public health worldwide.
..........계속
▶ 박문수(Ph.D) 자료 제공
과학기술연구개발정책 네이버카페 http://cafe.naver.com/RnD